Related Experiment Videos
A versatile biosensor device for continuous biomedical monitoring.
M M Rhemrev-Boom1, J Korf, K Venema
1Academic Hospital Groningen, Department of Biological Psychiatry, P.O. Box 30.001, 9700 RB Groningen, The Netherlands. m.m.rhemrev@med.rug.nl
Biosensors & Bioelectronics
|October 27, 2001
Summary
This study presents a miniaturized biosensor device for continuous in vivo monitoring. The novel nanoliter flow-through cell biosensor offers improved performance for biomedical applications.
Area of Science:
- Biomedical Engineering
- Analytical Chemistry
- Sensor Technology
Background:
- In vivo biosensor performance is limited by fouling and blood clotting, necessitating interfaces like ultrafiltration or microdialysis.
- Quantitative analyte recovery requires submicrolitre sampling, driving the need for small, versatile biosensor devices.
Purpose of the Study:
- To present a miniaturized biosensor device with a pulse-free pump and a nanoliter internal volume.
- To detail the production and construction of the biosensor's flow-through cell.
- To evaluate permselective membranes and develop an in situ electropolymerisation protocol for biological component immobilization.
Main Methods:
- Development and production of a miniaturized biosensor with a 10-20 nl internal volume and a pulse-free pump.
- Construction and optimization of a nanoliter flow-through cell.
- Testing of permselective membranes for bio-selector function.
- In situ electropolymerisation for immobilizing biological components.
- In vivo studies for monitoring glucose and lactate.
Main Results:
- A detailed protocol for producing a nanoliter flow-through cell was established.
- Permselective membranes were evaluated for their performance characteristics.
- Biosensors utilizing in situ electropolymerisation demonstrated successful monitoring of glucose and lactate.
- In vivo data from clinical applications validated the biosensor's utility.
Conclusions:
- The developed miniaturized biosensor device is suitable for direct connection to various interfaces.
- The nanoliter flow-through cell design and electropolymerisation protocol enable effective in vivo monitoring.
- This technology holds promise for advancing continuous biomedical monitoring applications.